I believe there was also an issue related to glucose levels as well, which then results in worse infection outcomes with this virus.
I just came across the following that might be of interest as well: https://www.eurekalert.org/pub_releases/2020-02/msa-arc022620.php
That was from late February and I’ve not seen anything providing any update on the trials they were starting.
Not sure if that is working as I was thinking, a decoy to get the virus to bind with something other then the cell and so neutralizing it.
I believe there was also an issue related to glucose levels as well, which then results in worse infection outcomes with this virus.
I just came across the following that might be of interest as well: https://www.eurekalert.org/pub_releases/2020-02/msa-arc022620.php
That was from late February and I’ve not seen anything providing any update on the trials they were starting.
Not sure if that is working as I was thinking, a decoy to get the virus to bind with something other then the cell and so neutralizing it.